Genedata Biologics advances end-to-end biologics R&D activities including antibody screening, protein engineering, and biologics production.
The version 2.0 provides new protein production modules supporting production process, including molecule definition and cloning, expression, purification, analytics, and quality control.
The new version is said to help in biologics discovery and protein sciences besides culture and bioprocess development, biopharmaceutical development, protein technologies, and protein supply departments.
Genedata CEO Othmar Pfannes said the latest functionality will address the bottlenecks in protein production such that biologics research groups, and development and manufacturing organizations will choose it as their platform.